National Registry and Cohort Study of Pulmonary Vascular Disease
NCT05368467 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2025-06-26
Summary
This is a observational、multicenter, prospective cohort study for patients with pulmonary hypertension (PH). The purposes of this study were to evaluate the etiology、clinical characteristics、treatment modalities, and outcomes of patients with PH;also to set up registration system of PH in China, to build a database of Chinese PH, to establish a web-based international standard data acquisition system for PH and a multicenter clinical research platform. The results of the study will provide a basis for the future national health policy for prevention and treatment of PH.
Conditions
Interventions
- COMBINATION_PRODUCT
-
The clinical course and disease management
The clinical course and disease management of pulmonary hypertension patients
Sponsors & Collaborators
-
Nanjing First Hospital, Nanjing Medical University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-29
- Primary Completion
- 2028-12-30
- Completion
- 2028-12-30
Countries
- China
Study Locations
More Related Trials
-
Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease
NCT02742909 ·Status: COMPLETED ·Phase: PHASE4
-
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
NCT06554301 ·Status: RECRUITING ·Phase: PHASE1
-
Pulmonary Hypertension Modality of Death and Validation of REVEAL Risk Score
NCT04677608 ·Status: UNKNOWN
-
Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific Therapy
NCT06587074 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension
NCT05437224 ·Status: COMPLETED ·Phase: PHASE3
-
Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs
NCT03863990 ·Status: COMPLETED
-
Endothelial Cell Activation and Total Pulmonary Resistance in PAH
NCT06035861 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study on the Treatment of Nonthrombotic Obstructive Pulmonary Hypertension
NCT06980584 ·Status: RECRUITING ·Phase: NA
-
Clinical Profile of Patients With Pulmonary Hypertension Due to Lung Diseases ( Single Center Experience)
NCT02774928 ·Status: UNKNOWN
-
Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study
NCT06753981 ·Status: RECRUITING
-
Pulmonary Arterial Denervation in Patients With Pulmonary Hypertension Associated With the Left Heart Failure
NCT02220335 ·Status: COMPLETED ·Phase: NA
-
Discovering Clinical Study Experiences of Patients With Pulmonary Hypertension
NCT05918458 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Pulmonary Vascular Reactivity Test in Patients With Pulmonary Arterial Hypertension and a Cardiac Shunt
NCT02138708 ·Status: WITHDRAWN ·Phase: NA
-
Metabolic Remodeling in Pulmonary Arterial Hypertension (PAH)
NCT04968210 ·Status: COMPLETED
-
The PAH Platform for Deep Phenotyping in Korean Subjects
NCT03933579 ·Status: UNKNOWN
-
The Exercise Capacity and Quality of Life in the Patients With IPAH and Secondary PH
NCT02647060 ·Status: COMPLETED
-
Safety and Efficacy of Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension
NCT03282266 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Triple-Combination Therapy in Severe PAH-CHD
NCT06196801 ·Status: ACTIVE_NOT_RECRUITING
-
Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH
NCT03841344 ·Status: UNKNOWN ·Phase: NA
-
Novel Index (PIMR) in PAH
NCT05812976 ·Status: COMPLETED
-
Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension
NCT00675051 ·Status: COMPLETED
-
Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan
NCT02042014 ·Status: COMPLETED ·Phase: PHASE3
-
Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Right Heart Catheterization With Acute Vasodilator Testing
NCT01275690 ·Status: WITHDRAWN
-
Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan
NCT01508780 ·Status: WITHDRAWN ·Phase: PHASE4
-
Real World Observational Study of Sotatercept for Pulmonary Hypertension
NCT06751082 ·Status: RECRUITING